Status:
COMPLETED
Netrin-1 and Placenta Accreta
Lead Sponsor:
Assiut University
Conditions:
Placenta Accreta
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
Netrin-1 is a secreted protein, which was first identified as a neuronal guidance factor. It is expressed in a multitude of tissues as pancreas, lung, breast, and placenta. Netrin-1 is a multifunction...
Eligibility Criteria
Inclusion
- Age between 20-40 years.
- Singleton pregnancy.
- Women with suspicion of PA by two-dimensional (2D) gray scale imaging and color Doppler flow mapping
Exclusion
- Multiple pregnancy,
- Fetal anomalies,
- Preterm premature rupture of membranes, or infection
- Any medical disorders, such as thyroid dysfunction, hypertension, and gestational diabetes
- Patients with known bleeding disorders or on anticoagulant therapy.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04683562
Start Date
December 1 2021
End Date
June 1 2022
Last Update
August 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Woman's Health Hospital
Asyut, Egypt, 71111